STAT

Federal rules threaten to discourage undocumented immigrants from vaccinating children

Pediatricians and public health officials are worried vaccination rates among children of immigrants will fall as new and stricter federal rules come into effect this autumn.
If vaccination rates drop among the children of immigrant families, it won’t only affect those individuals, experts say.

Pediatricians and public health officials are worried vaccination rates among children of immigrants will fall as new and stricter rules come into effect this autumn related to the public services available to people seeking to immigrate to the United States.

In fact, a number said they have seen a decline in immigrant families using preventive health care services for their children since the Trump administration published its proposed “public charge” update last fall — even when the children are U.S. citizens and are not subject to the rule.

Under the rule, noncitizens hoping to qualify for permanent residency —also known as a green card — can be denied if authorities deem them to be a drain on public coffers. The new rule defines a public charge as any noncitizen who receives benefits from public programs for more than 12 months over a three-year period. Use of two services in

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About MorphoSys Drug Risks, An AstraZeneca Admission, And More
MorphoSys is dealing with a safety issue with pelabresib, the experimental treatment for myelofibrosis and centerpiece of its proposed $3 billion acquisition by Novartis.
STAT2 min readCrime & Violence
STAT+: Pharmalittle: We’re Reading About A Medicare Price-negotiation Ruling, Pharma’s Slipping Reputation, And More
A U.S. judge dealt a blow to two drugmakers challenging the authority for Medicare to negotiate the prices of prescription drugs.
STAT2 min readAmerican Government
STAT+: Pharmalittle: We’re Reading About FTC Reviewing Novo-Catalent Deal, Amneal Opioid Settlement, And More
The FTC wants more information on a $16.5 million deal in which Novo Nordisk's parent company would purchase Catalent, a contract drug manufacturer.

Related Books & Audiobooks